Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapyJacqui Nimmo, James A. R. Nicoll, Ajay Verma et al.|Alzheimer s Research & Therapy|2020Cited by 48
The complement system in neurodegenerative diseasesJacqui Nimmo, B. Paul Morgan, Robert A.J. Byrne et al.|Clinical Science|2024Cited by 48
The Pattern of AQP4 Expression in the Ageing Human Brain and in Cerebral Amyloid AngiopathyRaisah Owasil, Roxana O. Carare, Ronan O’Neill et al.|International Journal of Molecular Sciences|2020Cited by 47
Amyloid-β and α-Synuclein Immunotherapy: From Experimental Studies to Clinical TrialsJacqui Nimmo, Jean‐Cosme Dodart, Louise Kelly et al.|Frontiers in Neuroscience|2021Cited by 40
Immunisation with UB-312 in the Thy1SNCA mouse prevents motor performance deficits and oligomeric α-synuclein accumulation in the brain and gutJacqui Nimmo, Roxana O. Carare, Jessica L. Teeling et al.|Acta Neuropathologica|2021Cited by 33